(Q39170630)

English

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study

scientific article published on August 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Souleymane Mboup

12

object named as

Souleymane Mboup

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

object named as

Amina Sow

10

0 references

Shevanthi Nayagam

object named as

Shevanthi Nayagam

19

0 references

object named as

Gibril Ndow

5

0 references

Umberto D'Alessandro

26

object named as

Umberto D'Alessandro

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

23

object named as

Tumani Corrah

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Coumba Touré Kane

11

object named as

Coumba Toure-Kane

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hilton C. Whittle

24

object named as

Hilton Whittle

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Simon D Taylor-Robinson

25

object named as

Simon D Taylor-Robinson

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Maud Lemoine

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yusuke Shimakawa

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Ramou Njie

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Makie Taal

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Isabelle Chemin

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sumantra Ghosh

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Harr F Njai

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Adam Jeng

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Penda Suso

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Saydiba Tamba

14

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Abdullah Jatta

15

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Louise Sarr

16

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Aboubacar Kambi

17

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

William Stanger

18

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jessica Howell

20

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Liliane Mpabanzi

21

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Ousman Nyan

22

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Maimuna Mendy

27

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Mark R Thursz

28

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PROLIFICA investigators

29

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

1 August 2016

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

The Lancet Global Health

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

e559-67

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for action

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Deferred donor care in a regional hospital blood center in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of reliability criteria for liver stiffness evaluation by transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term protection against carriage of hepatitis B virus after infant vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of hepatitis C virus among people of South Asian origin in Glasgow - results from a community based survey and laboratory surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2214-109X%2816%2930130-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2214-109X(16)30130-9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39170630&oldid=2113519523"